Trade Mark Journal No.2025/047 21 November 2025
WO0000001885331 (5,35,41,42,44)
Office of origin: United States of America
Date of International Registration:9 May 2025
Date of designation in the UK:
9 May 2025
The mark consists of a circle surrounded by two semi-circles on the left.
- Class 5
- Pharmaceutical products, pharmaceutical preparations, and pharmaceutical therapeutic preparations for the treatment of pregnancy-related complications and for sustaining fetal maturation.
- Class 35
- Promoting the interests of parents, expectant parents, persons experiencing pregnancy complications, and pregnancy complication survivors by means of public advocacy (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations).
- Class 41
- Educational and training services, namely, providing classes, seminars, and other training services in the medical and pharmaceutical fields related to pregnancy, pregnancy-related complications, and maternal fetal medicine and health.
- Class 42
- Laboratory research and analysis services in the fields of pharmaceuticals, medicines, and medical devices relating to pregnancy, pregnancy complications, and maternal fetal medicine and health.
- Class 44
- Providing medical information and services in the fields of pharmaceuticals, medicines, and medical devices as it relates to pregnancy, pregnancy complications, and maternal fetal medicine and health.
Comanche Biopharma Corp.
Representative: Brian J. Focarino Cooley LLP, 1299 Pennsylvania Avenue NW, Suite 700, Washington DC 20004, UNITED STATES OF AMERICA